CN Stock MarketDetailed Quotes

Zhejiang Huahai Pharmaceutical (600521)

Watchlist
  • 14.45
  • +0.36+2.56%
Market Closed Jun 12 15:00 CST
21.64BMarket Cap58.03P/E (TTM)

Zhejiang Huahai Pharmaceutical (600521) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Finished drug sales5B58.24%
Sales of raw materials and intermediates3.47B40.40%
Other business55.45M0.65%
Technical services44.9M0.52%
Other16.22M0.19%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Finished drug sales5B58.24%
Sales of raw materials and intermediates3.47B40.40%
Other business55.45M0.65%
Technical services44.9M0.52%
Other16.22M0.19%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Abroad4.28B49.84%
Domestic4.25B49.51%
Other business55.45M0.65%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
A critical window for U.S.-Iran talks has opened! According to Bloomberg, the U.S. and Iran are 'close' to signing an agreement around the u Show More